9 October 2021 - Pharmacists have raised the alarm over the influence of a US pharmaceutical corporation on Australian doctors who are signing trademark-stamped letters requesting their patients be given the company’s branded drugs rather than biosimilar medications that cost taxpayers less.

Pharmacists around the country are reporting receiving pro­forma letters from specialist rheumatologists, gastro-enterologists and public hospital clinics that have been supplied by the ­Illinois-based pharmaceutical company AbbVie to doctors instructing chemists to only dispense the branded version of the widely prescribed auto-immune medication adalimumab.

Read The Australian article